sábado, 30 de marzo de 2019

First gene therapy to treat rare blood disease nears European approval

First gene therapy to treat rare blood disease nears European approval

Daily Recap

First gene therapy to treat rare blood disease nears European approval

By ADAM FEUERSTEIN


RUBY WALLAU FOR STAT
There are dozens of biotech and pharma companies developing gene therapies for rare diseases today, but Bluebird was an early pioneer.

No hay comentarios:

Publicar un comentario